Literature DB >> 7810810

Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area.

P Wincker1, C Britto, J B Pereira, M A Cardoso, W Oelemann, C M Morel.   

Abstract

The feasibility of using DNA amplification by the polymerase chain reaction (PCR) for specific detection of Trypanosoma cruzi in human blood specimens was investigated. One hundred blood samples were collected in an endemic area of Minas Gerais, Brazil. They were submitted to DNA extraction and PCR amplification with kinetoplast DNA-specific primers using a simplified boiling procedure that linearized most minicircle molecules without the aid of chemical reagents. Samples that gave negative results were checked for possible inhibition of amplification using primers derived from a human-specific sequence, and those showing some level of inhibition were retested after a new DNA extraction. Of 86 patients previously diagnosed as chagasic by serologic techniques, 83 were positive in our PCR test (sensitivity = 96.5%), including all the xenodiagnosis-positive patients and 21 (87.5%) of 24 xenodiagnosis-negative individuals. In addition, four of six patients with doubtful serologic results were confirmed as positive by PCR. Our results suggest that the PCR may be a useful complement to serology in the diagnosis of Chagas' disease, and that it is the most powerful technique available for parasite detection in patients with chronic disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810810     DOI: 10.4269/ajtmh.1994.51.771

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  67 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

3.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

5.  Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.

Authors:  A L Basquiera; A Sembaj; A M Aguerri; M Omelianiuk; S Guzmán; J Moreno Barral; T F Caeiro; R J Madoery; O A Salomone
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

6.  Trypanosoma rangeli Tejera, 1920, in chronic Chagas' disease patients under ambulatory care at the Evandro Chagas Clinical Research Institute (IPEC-Fiocruz, Brazil).

Authors:  Maria Auxiliadora de Sousa; Tatiana da Silva Fonseca; Barbara Neves Dos Santos; Sheila Medeiros Dos Santos Pereira; Cristina Carvalhal; Alejandro Marcel Hasslocher Moreno
Journal:  Parasitol Res       Date:  2008-06-18       Impact factor: 2.289

7.  Trypanosoma cruzi infection in Mepraia gajardoi and Mepraia spinolai: the effect of feeding nymphs from the field.

Authors:  Camila Egaña; Fernanda Vergara; Ricardo Campos; Sylvia Ortiz; Carezza Botto-Mahan; Aldo Solari
Journal:  Am J Trop Med Hyg       Date:  2014-06-16       Impact factor: 2.345

8.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Trypanosoma cruzi genotypes in Mepraia gajardoi from wild ecotopes in northern Chile.

Authors:  Andrea Toledo; Fernanda Vergara; Ricardo Campos; Carezza Botto-Mahan; Sylvia Ortiz; Ximena Coronado; Aldo Solari
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

10.  Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease.

Authors:  W M Oelemann; M D Teixeira; G C Veríssimo Da Costa; J Borges-Pereira; J A De Castro; J R Coura; J M Peralta
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.